Arcus Biosciences Stock Filter Stocks by Fundamentals
| RCUS Stock | USD 15.94 0.50 3.24% |
Arcus Biosciences fundamentals help investors to digest information that contributes to Arcus Biosciences' financial success or failures. It also enables traders to predict the movement of Arcus Stock. The fundamental analysis module provides a way to measure Arcus Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arcus Biosciences stock.
Arcus | Shares Owned by Institutions |
Arcus Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Arcus Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Arcus Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Arcus Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Arcus Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Arcus Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arcus Biosciences' value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.2 M | Parkman Healthcare Partners Llc | 2024-09-30 | 1 M | Bnp Paribas Investment Partners Sa | 2024-09-30 | 931 K | Decheng Capital Llc | 2024-09-30 | 869.8 K | Ikarian Capital, Llc | 2024-09-30 | 744 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 714.5 K | Goldman Sachs Group Inc | 2024-09-30 | 703.3 K | Schonfeld Strategic Advisors Llc | 2024-09-30 | 673.8 K | Suvretta Capital Management, Llc | 2024-09-30 | 663.6 K | Blackrock Inc | 2024-06-30 | 9.8 M | Vanguard Group Inc | 2024-09-30 | 5.5 M |
Arcus Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (1.03) % | ||||
| Operating Margin | (2.19) % | ||||
| Current Valuation | 381.94 M | ||||
| Shares Outstanding | 91.51 M | ||||
| Shares Owned By Insiders | 40.00 % | ||||
| Shares Owned By Institutions | 60.05 % | ||||
| Number Of Shares Shorted | 7.57 M | ||||
| Price To Earning | 27.69 X | ||||
| Price To Book | 2.50 X | ||||
| Price To Sales | 5.55 X | ||||
| Revenue | 117 M | ||||
| Gross Profit | (176 M) | ||||
| EBITDA | (283 M) | ||||
| Net Income | (307 M) | ||||
| Cash And Equivalents | 1.05 B | ||||
| Cash Per Share | 14.48 X | ||||
| Total Debt | 11 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 6.22 X | ||||
| Book Value Per Share | 6.17 X | ||||
| Cash Flow From Operations | (306 M) | ||||
| Short Ratio | 8.48 X | ||||
| Earnings Per Share | (3.19) X | ||||
| Target Price | 33.2 | ||||
| Number Of Employees | 577 | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 1.46 B | ||||
| Total Asset | 1.09 B | ||||
| Retained Earnings | (849 M) | ||||
| Working Capital | 647 M | ||||
| Net Asset | 1.09 B |
About Arcus Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arcus Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arcus Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arcus Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.